Globoh Positive News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Globoh Positive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Globoh Positive Today - Breaking & Trending Today

OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Published: May 17, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

T Ai PeiUnited StatesSan FranciscoAdagloxad SimoleninKevin PoulosApostolia Maria TsimberidouMccormick CenterAmerican Society Of Clinical OncologyUniversity Of Texas Md Anderson Cancer CenterFutures BureauPharma IncPharma United States IncFirst In Class CancerAmerican SocietyClinical OncologyAntibody Drug ConjugateMing Tain LaiChief Scientific OfficerGloboh PositiveBreast CancerFirst In Human StudyGloboh Targeting Antibody Drug ConjugateAdvanced SolidDevelopmental TherapeuticsMolecularly Targeted Agents

OBI Pharma Inc.: OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth

Published: May 17, 2022

Poster Presentations to highlight the ongoing clinical studies targeting Globo H and AKR1C3TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer

Source: finanznachrichten.de

Related Topics:

T Ai PeiUnited StatesSan FranciscoAdagloxad SimoleninKostenloser WertpapierhandelKevin PoulosApostolia Maria TsimberidouMccormick CenterAmerican Society Of Clinical OncologyUniversity Of Texas Md Anderson Cancer CenterFutures BureauPharma IncPharma United States IncPoster PresentationsFirst In Class CancerAmerican SocietyClinical OncologyAntibody Drug ConjugateMing Tain LaiChief Scientific OfficerGloboh PositiveFirst In Human StudyGloboh Targeting Antibody Drug ConjugateAdvanced SolidApostolia Maria Tsimberidou Phd